- Oct 2024
-
x.com x.com
-
The similarity is because they are all saying roughly the same thing: Total (result) = Kinetic (cost) + Potential (benefit) Cost is either imaginary squared or negative (space-like), benefit is real (time-like), result is mass-like. Just like physics, the economic unfavourable models are the negative results. In economics, diversity of products is a strength as it allows better recovery from failure of any one, comically DEI of people fails miserably at this, because all people are not equal. Here are some other examples you will know if you do physics: E² + (ipc)² = (mc²)² (relativistic Einstein equation), mass being the result, energy time-like (potential), momentum the space-like (kinetic). ∇² - 1/c² ∂²/∂t² = (mc/ℏ)² (Klein-Gordon equation), mass is the result, ∂²/∂t² potential, ∇² is kinetic. Finally we have Dirac equation, which unlike the previous two as "sum of squares" is more like vector addition (first order differentials, not second). iℏγ⁰∂₀ψ + iℏγⁱ∂ᵢψ = mcψ First part is still the time-like potential, second part is the space-like kinetic, and the mass is still the result though all the same. This is because energy is all forms, when on a flat (free from outside influence) worksheet, acts just like a triangle between potential, kinetic and resultant energies. E.g. it is always of the form k² + p² = r², quite often kinetic is imaginary to potential (+,-,-,-) spacetime metric, quaternion mathematics. So the r² can be negative, or imaginary result if costs out way benefits, or work in is greater than work out. Useless but still mathematical solution. Just like physics, you always want the mass or result to be positive and real, or your going to lose energy to the surrounding field, with negative returns. Economic net loss do not last long, just like imaginary particles in physics.
in reply to Cesar A. Hidalgo at https://x.com/realAnthonyDean/status/1844409919161684366
via Anthony Dean @realAnthonyDean
-
- Apr 2023
-
-
Raworth, Kate. Doughnut Economics: Seven Ways to Think Like a 21st-Century Economist. White River Junction, Vermont: Chelsea Green Publishing, 2017.
-
- Jan 2022
-
psyarxiv.com psyarxiv.com
-
Strickland, J. C., Stoops, W., Banks, M., & Gipson-Reichardt, C. D. (2022). Logical Fallacies and Misinterpretations that Hinder Progress in Translational Addiction Neuroscience. PsyArXiv. https://doi.org/10.31234/osf.io/frd5e
-
- Feb 2021
-
advances.sciencemag.org advances.sciencemag.org
-
Stewart, A. J., McCarty, N., & Bryson, J. J. (2020). Polarization under rising inequality and economic decline. Science Advances, 6(50), eabd4201. https://doi.org/10.1126/sciadv.abd4201
-
-
-
Study shows vaccine nationalism could cost rich countries US$4.5 trillion. (2021, January 25). ICC - International Chamber of Commerce. https://iccwbo.org/media-wall/news-speeches/study-shows-vaccine-nationalism-could-cost-rich-countries-us4-5-trillion/
Tags
- model
- is:news
- lang:en
- nationalism
- treatment
- COVID-19
- funding
- global
- government
- ICC
- development
- vaccine
- economic
- vaccination
- economy
Annotators
URL
-
- Aug 2020
-
www.nber.org www.nber.org
-
Avery, C., Bossert, W., Clark, A., Ellison, G., & Ellison, S. F. (2020). Policy Implications of Models of the Spread of Coronavirus: Perspectives and Opportunities for Economists (Working Paper No. 27007; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27007
-
-
www.nber.org www.nber.org
-
Berger, D. W., Herkenhoff, K. F., & Mongey, S. (2020). An SEIR Infectious Disease Model with Testing and Conditional Quarantine (Working Paper No. 26901; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w26901
-
-
www.nber.org www.nber.org
-
Chari, Varadarajan V, Rishabh Kirpalani, and Christopher Phelan. ‘The Hammer and the Scalpel: On the Economics of Indiscriminate versus Targeted Isolation Policies during Pandemics’. Working Paper. Working Paper Series. National Bureau of Economic Research, May 2020. https://doi.org/10.3386/w27232.
-
-
-
Bethune, Z. A., & Korinek, A. (2020). Covid-19 Infection Externalities: Trading Off Lives vs. Livelihoods (Working Paper No. 27009; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27009
-
- Jul 2020
-
www.cambridge.org www.cambridge.org
-
Al-Ubaydli, O., Lee, M. S., List, J. A., Mackevicius, C. L., & Suskind, D. (undefined/ed). How can experiments play a greater role in public policy? Twelve proposals from an economic model of scaling. Behavioural Public Policy, 1–48. https://doi.org/10.1017/bpp.2020.17
-
- May 2020
-
www.repository.cam.ac.uk www.repository.cam.ac.uk
-
Toxvaerd, F. M. O. (2020). Equilibrium Social Distancing [Working Paper]. Faculty of Economics, University of Cambridge. https://doi.org/10.17863/CAM.52489
-
- Jan 2020
-
www.forbes.com www.forbes.com
-
Gujarat often produced growth faster than the national average, fewer regulations, better infrastructure and less corruption
-
- Nov 2018
-
www.the-hospitalist.org www.the-hospitalist.org
-
“It doesn’t just help make hospitalists work better. It makes nursing better. It makes surgeons better. It makes pharmacy better.”
-
“This has all been an economic move,” she says. “People sort of forget that, I think. It was discovered by some of the HMOs on the West Coast, and it was really not the HMOs, it was the medical groups that were taking risks—economic risks for their group of patients—that figured out if they sent … primary-care people to the hospital and they assigned them on a rotation of a week at a time, that they can bring down the LOS in the hospital. “That meant more money in their own pockets because the medical group was taking the risk.” Once hospitalists set up practice in a hospital, C-suite administrators quickly saw them gaining patient share and began realizing that they could be partners. “They woke up one day, and just like that, they pay attention to how many cases the orthopedist does,” she says. “[They said], ‘Oh, Dr. Smith did 10 cases last week, he did 10 cases this week, then he did no cases or he did two cases. … They started to come to the hospitalists and say, ‘Look, you’re controlling X% of my patients a day. We’re having a length of stay problem; we’re having an early-discharge problem.’ Whatever it was, they were looking for partners to try to solve these issues.” And when hospitalists grew in number again as the model continued to take hold and blossom as an effective care-delivery method, hospitalists again were turned to as partners. “Once you get to that point, that you’re seeing enough patients and you’re enough of a movement,” Dr. Gorman says, “you get asked to be on the pharmacy committee and this committee, and chairman of the medical staff, and all those sort of things, and those evolve over time.”
-
